Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
China
Harbin Medical University Cancer Hospital, Harbin The First Affiliated Hospital of Anhui Medical University, Hefei Zhongshan Hospital, Fudan University, Shanghai The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an The Second Affiliated Hospital of Xi'an Jiaotong University, Zhengzhou Last updated February 2026